BioTime names its COO Adi Mohanty as Co-CEO

– USA, CA – BioTime, Inc. (NYSE and TASE: BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, reported today that its Board of Directors has appointed Adi Mohanty to serve with Michael D.…